Related Experiment Video
Updated: Jun 25, 2026
09:57
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
Published on: June 28, 2021
Structure-Guided PEGylation of IL-1Ra Preserves Fold and Antagonist Function
Işılay Göktan1, Çaǧdaş Daǧ2, Ahmet Gül3
1Chemical and Biological Engineering, Koç University, Rumelifeneri Yolu, Sariyer, Istanbul 34450, Turkey.
Molecular Pharmaceutics
|June 23, 2026
Summary
This study developed a framework to compare PEGylation methods for protein therapeutics like Anakinra. Site-specific PEGylation created a homogeneous product with preserved structure and function, unlike random methods.
Area of Science:
- Bioconjugation Chemistry
- Protein Engineering
- Pharmacology
Background:
- PEGylation of protein therapeutics like Anakinra (IL-1Ra) aims to improve pharmacokinetics but requires understanding conjugation impacts.
- Anakinra's short half-life necessitates frequent injections and is linked to amyloidosis, highlighting the need for improved formulations.
- Current PEGylation strategies lack residue-level characterization, limiting rational design of homogeneous and functional conjugates.
Purpose of the Study:
- To establish a head-to-head comparison of site-specific thiol-maleimide versus random amino-coupling for PEGylating IL-1Ra.
- To characterize the homogeneity, receptor engagement, and structural integrity of resulting PEGylated IL-1Ra conjugates.
- To provide a transferable analytical framework for designing PEGylated cytokine therapeutics.
Main Methods:
- Utilized uniformly 15N-labeled recombinant IL-1Ra variant (M143V) for head-to-head comparison of conjugation chemistries.
- Employed a 5-20 kDa PEG ladder with substoichiometric PEG:protein feed (0.5:1) for both site-specific and random coupling.
- Assessed product homogeneity, antagonist activity (HEK-Blue reporter cells), and structural integrity (1H-15N HSQC NMR).
Main Results:
- Site-specific thiol-maleimide coupling yielded high conversion (~81%) and a homogeneous single-species di-PEGylated conjugate.
- Random amino-coupling resulted in heterogeneous mixtures across all PEG sizes (~33-36% conversion).
- All PEGylated conjugates retained maximal efficacy, with IC50 shifts indicating size- and chemistry-dependent steric modulation of receptor engagement; NMR confirmed preserved global fold and localized perturbations near modification sites.
Conclusions:
- Site-specific thiol-maleimide PEGylation offers superior control over product homogeneity and maintains structural integrity and biological activity.
- The developed analytical framework is crucial for the rational design and selection of PEGylated protein therapeutics.
- This approach enables informed design choices for PEGylated cytokine therapeutics, balancing efficacy, safety, and pharmacokinetic profiles.
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:29Protein Folding Quality Check in the RER
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...